Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2024 · 10-Q
Revenue$303.43M$303.43M+3.2% vs Q3 2023 Net Income$49.06M$49.06M−30.1% vs Q3 2023 EPS Diluted$0.31$0.31−27.9% vs Q3 2023 Gross Profit$204,599,000+1.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$80,986,000+60.3% Free Cash Flowderived$64,545,000+66.4% Margins · derivedGross margin67.4%−1.3 pt vs Q3 2023
Operating margin22.1%−5.2 pt vs Q3 2023
Net margin16.2%−7.7 pt vs Q3 2023
ended Mar 31, 2024 · filed May 6, 2024 · 36 d after period end